title: Comparison of Caffeine and d-amphetamine in Cocaine-Dependent Subjects: Differential Outcomes on Subjective and Cardiovascular Effects, Reward Learning, and Salivary Paraxanthine.
abstract: Due to indirect modulation of dopamine transmission, adenosine receptor antagonists may be useful in either treating cocaine use or improving disrupted cognitive-behavioral functions associated with chronic cocaine use. To compare and contrast the stimulant effects of adenosine antagonism to direct dopamine stimulation, we administered 150 mg and 300 mg caffeine, 20 mg amphetamine, and placebo to cocaine-dependent vs. healthy control subjects, matched on moderate caffeine use. Data were obtained on measures of cardiovascular effects, subjective drug effects (ARCI, VAS, DEQ), and a probabilistic reward-learning task sensitive to dopamine modulation. Levels of salivary caffeine and the primary caffeine metabolite paraxanthine were obtained on placebo and caffeine dosing days. Cardiovascular results revealed main effects of dose for diastolic blood pressure and heart rate; follow up tests showed that controls were most sensitive to 300 mg caffeine and 20 mg amphetamine; cocaine-dependent subjects were sensitive only to 300 mg caffeine. Subjective effects results revealed dose × time and dose × group interactions on the ARCI A, ARCI LSD, and VAS 'elated' scales; follow up tests did not show systematic differences between groups with regard to caffeine or d-amphetamine. Large between-group differences in salivary paraxanthine (but not salivary caffeine) levels were obtained under both caffeine doses. The cocaine-dependent group expressed significantly higher paraxanthine levels than controls under 150 mg and 3-4 fold greater levels under 300 mg at 90 min and 150 min post caffeine dose. However, these differences also covaried with cigarette smoking status (not balanced between groups), and nicotine smoking is known to alter caffeine/paraxanthine metabolism via cytochrome P450 enzymes. These preliminary data raise the possibility that adenosine antagonists may affect cocaine-dependent and non-dependent subjects differently. In conjunction with previous preclinical and human studies, the data suggest that adenosine modulating drugs may have value in the treatment of stimulant use disorders.
authors.affiliation: Center for Neurobehavioral Research on Addictions, Department of Psychiatry & Behavioral Sciences, University of Texas Health Science Center - Houston, Houston, TX USA.
authors.forename: Scott D
authors.initials: SD
authors.lastname: Lane
authors.affiliation: Center for Neurobehavioral Research on Addictions, Department of Psychiatry & Behavioral Sciences, University of Texas Health Science Center - Houston, Houston, TX USA.
authors.forename: Charles E
authors.initials: CE
authors.lastname: Green
authors.affiliation: Center for Neurobehavioral Research on Addictions, Department of Psychiatry & Behavioral Sciences, University of Texas Health Science Center - Houston, Houston, TX USA.
authors.forename: Joy M
authors.initials: JM
authors.lastname: Schmitz
authors.affiliation: Center for Neurobehavioral Research on Addictions, Department of Psychiatry & Behavioral Sciences, University of Texas Health Science Center - Houston, Houston, TX USA.
authors.forename: Nuvan
authors.initials: N
authors.lastname: Rathnayaka
authors.affiliation: Center for Human Toxicology, University of Utah, Salt Lake City, UT, USA.
authors.forename: Wendy B
authors.initials: WB
authors.lastname: Fang
authors.affiliation: Integrative Neurobiology, Intramural Research Program, National Institute on Drug Abuse, Baltimore, MD, USA.
authors.forename: Sergi
authors.initials: S
authors.lastname: Ferré
authors.affiliation: Division on Addictions, Department of Psychiatry, Virginia Commonwealth University, Richmond, VA, USA.
authors.forename: F Gerard
authors.initials: FG
authors.lastname: Moeller
keywords: Adenosine A1/A2 receptor; Caffeine; Cardiovascular effects; Cocaine dependence; Human; Paraxanthine; Reward learning; Subjective effects; d-amphetamine